脑内钆沉积:使用广义相加模型分析其与多种钆对比剂的相关性
本回顾性研究纳入122例接受双倍剂量钆对比剂增强磁共振成像的患者,由两名放射科医生计算苍白球与丘脑信号强度比、齿状核与脑桥信号强度比及基线与末次检查间的相对变化。采用广义相加模型分析显示,齿状核与脑桥信号强度比的相对变化与钆双胺(p=0.006)和钆喷酸葡胺(p<0.001)相关,而与其他钆对比剂无关;苍白球与丘脑信号强度比的相对变化与钆对比剂给药无关。
要点
- 线性钆对比剂钆双胺和钆喷酸葡胺与齿状核T1信号增高相关,大环类钆对比剂未见此关联。
- 齿状核信号变化与特定线性钆对比剂的给药次数相关,苍白球信号变化与给药无关。
- 信号变化的差异可能反映不同钆对比剂稳定性的差异。
核心结论
- 既往使用线性钆对比剂钆双胺和钆喷酸葡胺与齿状核T1信号强度增高相关,而大环类钆对比剂未显示此关联。
研究设计与样本
- 回顾性研究,纳入122例接受双倍剂量钆对比剂增强磁共振成像的患者;由两名放射科医生计算信号强度比及相对变化,采用广义相加模型分析相对变化与各因素(包括每种钆对比剂给药次数)的关系。
关键影像表现/征象
- 齿状核与脑桥信号强度比的相对变化与钆双胺(p=0.006)和钆喷酸葡胺(p<0.001)相关,与其他钆对比剂无关。
- 苍白球与丘脑信号强度比的相对变化与钆对比剂给药无关。
- 观察者间一致性几乎完美(0.99;95% CI:0.99-0.99)。
诊断标准与关键数值
- 6例(4.9%)接受线性钆对比剂(平均给药次数20.8次;范围15-30次)。
- 44例(36.1%)接受大环类钆对比剂(平均26.1次;范围14-51次)。
- 72例(59.0%)接受两种类型钆对比剂(平均31.5次;范围12-65次)。
临床应用与阅片要点
- 阅片时可关注齿状核T1信号增高,尤其在有线性钆对比剂钆双胺或钆喷酸葡胺使用史的患者中。
- 齿状核信号变化与特定线性钆对比剂的给药次数相关,评估时应结合对比剂类型和给药次数。
- 大环类钆对比剂未显示与齿状核信号变化相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the relationship between the number of administrations of various gadolinium-based contrast agents (GBCAs) and increased T1 signal intensity in the globus pallidus (GP) and dentate nucleus (DN).
METHODS: This retrospective study included 122 patients who underwent double-dose GBCA-enhanced magnetic resonance imaging. Two radiologists calculated GP-to-thalamus (TH) signal intensity ratio, DN-to-pons signal intensity ratio and relative change (Rchange) between the baseline and final examinations. Interobserver agreement was evaluated. The relationships between Rchange and several factors, including number of each GBCA administrations, were analysed using a generalized additive model.
RESULTS: Six patients (4.9%) received linear GBCAs (mean 20.8 number of administration; range 15-30), 44 patients (36.1%) received macrocyclic GBCAs (mean 26.1; range 14-51) and 72 patients (59.0%) received both types of GBCAs (mean 31.5; range 12-65). Interobserver agreement was almost perfect (0.99; 95% CI: 0.99-0.99). Rchange (DN:pons) was associated with gadodiamide (p = 0.006) and gadopentetate dimeglumine (p < 0.001), but not with other GBCAs. Rchange (GP:TH) was not associated with GBCA administration.
CONCLUSIONS: Previous administration of linear agents gadoiamide and gadopentetate dimeglumine is associated with increased T1 signal intensity in the DN, whereas macrocyclic GBCAs do not show an association.
KEY POINTS: • Certain linear GBCAs are associated with T1 signal change in the dentate nucleus. • The signal change is related to the administration number of certain linear GBCAs. • Difference in signal change may reflect differences in stability of agents.
引用
- Bae S, Lee HJ, Han K, et al. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model. Eur Radiol. 2017. PMID: 28083696. doi:10.1007/s00330-016-4724-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。